Aquestive Therapeutics Revenue and Competitors

Claim your profile

Warren, NJ USA

Location

$199.6M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Aquestive Therapeutics's estimated annual revenue is currently $6.7M per year.(i)
  • Aquestive Therapeutics received $73.9M in venture funding in August 2018.
  • Aquestive Therapeutics's estimated revenue per employee is $50,677
  • Aquestive Therapeutics's total funding is $199.6M.

Employee Data

  • Aquestive Therapeutics has 133 Employees.(i)
  • Aquestive Therapeutics grew their employee count by -11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M391850%N/AN/A
#2
$4180M1816513%$550MN/A
#3
$2.7M336%N/AN/A
#4
$6.7M133-11%$199.6MN/A
#5
$7.4M90429%N/AN/A
#6
$3M3633%N/AN/A
#7
$87.8M43716%N/AN/A
#8
$4.1M50-2%N/AN/A
#9
$41M2043%N/AN/A
#10
$5M25-19%N/AN/A

Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.

keywords:N/A

$199.6M

Total Funding

133

Number of Employees

$6.7M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aquestive Therapeutics News

2022-04-17 - Where Will Aquestive Therapeutics Inc (AQST) Stock Go Next After It Is Down 6.02% in a Week?

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet...

2022-04-13 - Aquestive Therapeutics Announces Common Stock Purchase ...

Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an...

2022-04-13 - Aquestive Therapeutics Reports Positive Topline Data from ...

Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an...

2019-09-03 - Short Interest in Aquestive Therapeutics Inc (NASDAQ:AQST ...

Aquestive Therapeutics Inc (NASDAQ:AQST) was the target of a significant decline in short interest during the month of July. As of July 31st, ...

2019-09-03 - Market Sentiment Around Loss-Making Aquestive ...

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST): Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.4M1416%N/A
#2
$21M147-16%N/A
#3
$15M153168%N/A
#4
$25.6M155N/AN/A
#5
$41.8M1551%N/A

Aquestive Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-08-16$73.9MUndisclosedBMO Capital MarketsArticle